Note: Descriptions are shown in the official language in which they were submitted.
SINGLE-USE INJECTOR OF LOW COST
Field of the Invention
[0001] The present invention relates generally to an injection device for
dispensing a
medicament, and more particularly to a low-cost, single-use injection device.
Background of the Invention
[0002] Various injection devices are known in the art. Many such injection
devices,
however, require medical training for proper use. In addition, many such
injection devices
are expensive. Thus, there is a need to provide a low-cost, intuitive
injection device that can
be properly used by untrained or minimally trained people for self-injection
or injection of
others. For example, such a needed device could be used for inoculations in
developing
areas of the world where medical care is difficult to obtain, or for a parent
to inoculate a
child. In addition, needles may be intimidating to some patients. Accordingly,
it is desirable
for an injection device to hide the needle from the user, both before and
after the injection.
Summary of the Invention
[0003] An aspect of the present invention is to provide a low-cost, single-
use injection
device. Another aspect of the present invention is to provide an intuitive
injection device
that can be properly used by untrained or minimally trained people for self-
injection or
injection of others. Yet another aspect of the present invention is to provide
an injection
device in which the needle is hidden prior to injection and shielded
subsequent to injection.
[0004] The foregoing and/or other aspects of the present invention are
achieved by
providing an injection device, including a safety shield and a housing. The
safety shield has
a first end and a surface disposed at a second end thereof for contacting a
patient's skin, and
a shield tab extending therefrom. The housing is slidably disposed with
respect to the safety
shield and includes a guide groove for engaging the shield tab to guide
movement of the
1
CA 2978588 2017-09-07
housing relative to the safety shield. The guide groove has first and second
axial portions
and a substantially helical portion connecting the first and second axial
portions. The device
also includes a medicament container connected with the housing and having a
needle
affixed thereto in communication with a medicament disposed within the
medicament
container. The medicament container is displaceable relative to the safety
shield from an
initial position to an injection position, to a withdrawn position. The device
additionally
includes a biasing member biasing the medicament container away from the
safety shield
and an injector member slidably disposed relative to the medicament container,
for
expelling the medicament from the medicament container.
[0005] The foregoing and/or other aspects of the present invention are also
achieved by
providing an injection device, including a safety shield having a first end
and a surface
disposed at a second end thereof for contacting a patient's skin, and a
medicament container
slidably connected to the safety shield. The medicament container includes a
needle affixed
thereto in communication with a medicament disposed within the medicament
container.
The medicament container is displaceable relative to the safety shield from an
initial
position to an injection position, to a withdrawn position. The device also
includes an
injector member having a plunger and a stopper disposed at a first end of the
plunger, a
biasing member biasing the medicament container away from the safety shield,
and a
housing slidably disposed with respect to both the safety shield and the
medicament
container. The housing includes a cantilevered upper locking arm selectively
preventing
displacement of the housing and the plunger relative to the medicament
container. One of
the upper locking arm and the safety shield includes a ramp and the remaining
one of the
upper locking arm and the safety shield includes a corresponding radial
protrusion. Upon
displacement of the medicament container from the initial position to the
injection position
in which the needle extends beyond the safety shield, the ramp contacts the
radial protrusion
to radially displace a free end of the upper locking arm, to permit movement
of the housing
relative to the medicament container.
[0006] The foregoing and/or other aspects of the present invention are also
achieved by
providing a an injection device, including a safety shield having a surface
for contacting a
patient's skin, an inner housing slidably connected to the safety shield and
having a cam
track with first and second portions, a needle hub slidably connected to the
inner housing to
move from a first position to a second position relative thereto, and a double-
ended needle
2
CA 2978588 2017-09-07
affixed to the needle hub. The device also includes a medicament container for
holding a
medicament, slidably connected to the safety shield, a stopper slidably
disposed in the
medicament container, a biasing member disposed within the safety shield and
biasing the
medicament container in a first direction, and a needle shield for selectively
covering a first
end of the needle, the needle shield having at least one cam tab slidably
engaged with the
cam track. Displacement of the cam tab along the first portion of the cam
track displaces the
needle hub to the second position, piercing the stopper with the needle.
[0007] Additional and/or other aspects and advantages of the present invention
will be
set forth in part in the description that follows and, in part, will be
apparent from the
description, or may be learned by practice of the invention.
Brief Description of the Drawings
[0008] The above and/or other aspects and advantages of embodiments of the
invention
will be more readily appreciated from the following detailed description,
taken in
conjunction with the accompanying drawings, in which:
FIG. 1 is a perspective view of an injection device in accordance with an
embodiment of the present invention;
FIG 2 is a cross-sectional view of the device of FIG 1 in an initial state;
FIG. 3 is a perspective view of a safety shield of the device of FIG 1;
FIG. 4 is a perspective view of a housing of the device of FIG. 1;
FIG. 5 is a cross-sectional view of the housing of FIG. 4 taken along line 5-5
of
FIG. 4;
FIGS. 6-8 are cross-sectional views illustrating operation of the device of
FIG 1;
FIG. 9 is a perspective view of the device of FIG. 1 in a post-injection safe
state;
FIG. 10 is a perspective view of an injection device in accordance with
another
embodiment of the present invention;
FIG. 11 is a cross sectional view of the device of FIG 10 in an initial state;
FIG. 12 is a perspective view of a housing of the device of FIG 10;
FIG. 13 is a cross-sectional view of the housing taken along line 13-13 of
FIG.
12;
3
CA 2978588 2017-09-07
FIG. 14 is a cross sectional view of the device of FIG. 10 in an injection
state;
FIG. 15 is a cross-sectional view of the device of FIG. 10 subsequent to
injection
of a medicament;
FIG. 16 is a cross-sectional view of the device of FIG 10 in a post-injection
safe
state;
FIG. 17 is a perspective view of an injection device in accordance with
another
embodiment of the present invention;
FIG. 18 is a cross-sectional view of the device of FIG. 17 taken along line 18-
18
of FIG. 17;
FIG. 19 is a partial cross-sectional view of an inner housing of the device of
FIG.
17;
FIG. 20 is a cross-sectional view of the device of FIG 17 with a needle-
pierced
stopper;
FIG. 21 is a cross-sectional view of the device of FIG. 17 with a needle
shield
removed;
FIG. 22 is a cross-sectional view of the device of FIG. 17 with the needle
deployed;
FIG. 23 is a cross-sectional view of the device of FIG. 17 subsequent to
injection
of a medicament; and
FIG. 24 is a cross-sectional view of the device of FIG 17 in a post-injection
safe
state.
Detailed Description of Exemplary Embodiments
[0009] Reference will now be made in detail to embodiments of the present
invention,
examples of which are illustrated in the accompanying drawings, wherein like
reference
numerals refer to the like elements throughout. The descriptions of these
embodiments
exemplify the present invention by referring to the drawings.
[0010] FIG. 1 is a perspective view of an injection device 100 in accordance
with an
embodiment of the present invention. The injection device 100 includes a
safety shield 104,
a housing 108, and an injector member or injector button 112. The housing 108
is slidably
connected with the safety shield 104. The injection device 100 also includes a
removable
needle shield 116.
4
CA 2978588 2017-09-07
100111 FIG 2 is a cross-sectional view illustrating the injection device
100 in an initial
state. As shown in FIG. 2, injection device 100 also includes a medicament
container 120
with the needle 124 fixed thereto and a biasing member 128, such as a spring
128.
According to one embodiment, the medicament container 120 includes a flexible
blister 132
with a hub 136 for holding the needle 124. The needle 124 is in fluid
connection with the
flexible blister 132 via the hub 136. An example of such a medicament
container is
disclosed in U.S. No. 4,955,871 to Thomas. According to one embodiment, the
medicament
container 120 is fixedly connected with the housing 108. According to another
embodiment
(not shown), the medicament container includes a double ended needle that
punctures a
valve membrane when the needle shield is pushed rearward. This configuration
acts as an
anti-tamper, anti-re-use feature.
100121 FIG 2 also illustrates that the injector button 112 includes an
internal slot 140
axially aligned with the flexible blister 132. In addition, FIG. 2 illustrates
that the housing
108 includes inner and outer walls 144 and 148. The biasing member 128 is
disposed
between the inner and outer walls 144 and 148 and the injector button 112 and
the
medicament container 120 are disposed radially within the inner wall 144. The
injector
button 112 is slidably disposed relative to the medicament container 120 and
the inner wall
144.
[0013] The inner wall 144 has a pair of detents, including an initial detent
152 and a
locking detent 156. According to one embodiment, the detents 152 and 156 are
circumferential recesses on an interior surface of the inner wall 144.
According to another
embodiment, the detents 152 and 156 are discontinuous circumferential recesses
disposed
on the interior surface of the inner wall 144. The injector button 112
includes a button
projection 158 disposed at a distal end thereof and having a shape
corresponding to the
detents 152 and 156. The button projection 158 and the initial detent 152
interact to prevent
proximal movement of the injector button 112 relative to the housing 108
subsequent to the
button projection 158 engaging the initial detent 152. Similarly, as discussed
in greater
detail below, the button projection 158 and the locking detent 156 interact to
prevent
proximal movement of the injector button 112 relative to the housing 108
subsequent to the
button projection 158 engaging the locking detent 156.
CA 2978588 2017-09-07
[0014] As shown in FIGS. 2 and 3, the safety shield 104 is substantially
cylindrical and
has a depth stop 160 for limiting penetration of the needle 124 into a
patient's skin. The
safety shield 104 also includes a shield tab 164 radially projecting from a
flange 168
disposed at a proximal end of the safety shield 104. The flange 168 provides a
bearing
surface for a distal end of the biasing member 128 and the shield tab 164
interacts with a
guide groove 172 in the housing 108 to guide movement of the housing 108
relative to the
safety shield 104. The distal end of the safety shield 104 defines a surface
170 for
contacting a patient's skin.
[0015] As shown in FIG. 4, the housing 108 includes a cantilevered upper
flexible arm
176 and a cantilevered lower flexible arm 180. As described in greater detail
below, the
upper flexible arm 176 and the lower flexible arm 180 are locking members of
the guide
groove 172. FIG. 5 is a cross-sectional view of the housing 108 taken along
line 5-5 of FIG
4. As shown in FIG. 5, the guide groove 172 includes first and second
substantially axial
portions 184 and 188 and a substantially helical portion 192 connecting the
first and second
axial portions 184 and 188. According to one embodiment, for molding purposes,
the
substantially helical portion 192 cuts through the housing 108. As discussed
in greater detail
below, also shown in FIG. 5, the upper flexible arm 176 includes a ramp 194
disposed at the
free end of an internal side thereof. Additionally, the lower flexible arm 180
includes a ramp
hook 196.
[0016] FIGS. 6-8 are cross-sectional views illustrating operation of the
injection device
100. To operate the device, a user first removes the needle shield 116 and
places the surface
170 of the safety shield 104 on a patient's skin 194. Subsequently, the user
depresses the
injector button 112 to displace the medicament container to an injection
position. The force
required to compress the biasing member 128 and the force required to
penetrate the user's
skin with the needle 124 are less than that required to displace the button
projection 158
from the initial detent 152. Accordingly, when the user depresses the injector
button 112, the
housing 108 slides distally relative to the safety shield 104 and the needle
124 penetrates the
user's skin 198, stopping at a predetermined depth when the hub 136 of the
medicament
container 120 contacts the depth stop 160, as shown in FIG. 6.
[0017] During this distal displacement of the housing 108 relative to the
safety shield
104, the shield tab 164 engages the first axial portion 184 of the guide
groove 172 and
6
CA 2978588 2017-09-07
travels proximally relative thereto. In other words, the engagement of the
shield tab 164 and
the first axial portion 184 constrains the displacement of the housing 108
relative to the
safety shield 104 to be axial and prevents rotation of the housing 108
relative to the safety
shield 104. As the hub 136 nears the depth stop 160, the shield tab 164 passes
the ramp 194
and radially displaces the free end of the upper flexible arm 176. As the hub
136 engages
the depth stop 160, the shield tab 164 completes passing the ramp 194 and
reaches the
proximal end of the first axial portion 184. After the shield tab 164 passes
the ramp 194, the
free end of the upper flexible arm 176 snaps back to form a portion of the
helical portion
192 of the guide groove 172 and to prevent subsequent axial movement of the
shield tab
164 in the first axial portion 184.
[0018] Turning to FIG. 7, as the user continues to depress the injector
button 112, the
button projection 158 displaces from the initial detent 152 and the injector
button 112
displaces distally relative to the inner wall 144 and the medicament container
120 until the
button projection 158 engages the locking detent 156. During this distal
displacement of the
injector button, the walls of the internal slot 140 engage and compress the
flexible blister
132 and expel the medicament from the flexible blister 132 into the patient.
Once the button
projection 158 engages the locking detent 156 (defining an injection state),
the
corresponding shapes thereof prevent subsequent proximal displacement of the
injector
button 112 relative to the housing 108. In addition, once the medicament is
injected, the
proximal end of the injector button 112 is disposed sufficiently close to the
proximal end of
the housing 108 that a user cannot gain a purchase on the injector button 112
to attempt
proximal displacement of the injector button 112. According to one embodiment,
once the
medicament is injected, the proximal end of the injector button 112 is
substantially flush
with the proximal end of the housing 108.
[0019] Subsequent to the injection of the medicament, the user releases
the injector
button 112 and the biasing member 128 proximally displaces the housing 108 (as
well as the
medicament container 120 and the injector button 112) relative to the safety
shield 104,
thereby displacing the medicament container 120 (and the needle 124) to a
withdrawn
position. Because the shield tab 164 engages the helical portion 192 of the
guide groove
172, the during a first portion of the proximal displacement, the housing 108
rotates until
the shield tab 164 reaches the proximal end of the second axial portion 188.
At this point,
the biasing member 128 continues to proximally displace the housing .108 and
the
7
CA 2978588 2017-09-07
engagement of the shield tab 164 in the second axial portion 188 constrains
the proximal
displacement to be axial. As the housing 108 nears completion of its proximal
displacement,
the shield tab 164 passes the ramp hook 196 of the lower flexible arm 180 and
radially
displaces the free end of the lower flexible arm 180. And as the housing 108
completes its
proximal displacement (shown in FIGS. 8 and 9), the shield tab 164 completes
passing the
ramp hook 196 and reaches the distal end of the second axial portion 188.
After the shield
tab 164 passes the ramp hook 196, the free end of the lower flexible arm 180
snaps back to
prevent subsequent axial movement of the shield tab 164 in the second axial
portion 188. In
other words, the free end of the lower flexible arm 180 locks the shield tab
164 and prevents
subsequent displacement of the housing 108 relative to the safety shield 104,
thereby fixing
the injection device 100 in a post-injection safe state.
[0020] FIG. 10 is a perspective view of an injection device 200 in accordance
with
another embodiment of the present invention and FIG 11 is a cross sectional
view of the
injection device 200. As shown in FIG. 10, the injection device 200 includes a
safety shield
204 and a housing 208. Although not illustrated, the injection device 200 also
includes a
removable needle shield. The housing 208 slidably connects to the safety
shield 204. As
shown in FIG. 11, the injection device 200 also includes an injector member
212 (including
a plunger 214 and a stopper 216) that slidably connects with a medicament
container 220,
which has a needle 224 affixed to a distal end thereof. Further, the injection
device 200
includes a biasing member 228 biasing the medicament container 220 proximally
away
from the safety shield 204. The needle 224 communicates with a medicament
disposed
within the medicament container 220. Like the medicament container 120, the
medicament
container 220 is displaceable relative to the safety shield 204 from an
initial position (shown
in FIG. 11), to an injection position (shown in FIG. 14), to a withdrawn
position (shown in
FIG. 16). In addition, the safety shield 204 (having a depth stop 232, a
flange 236, and a
shield tab 240) is substantially similar to the safety shield 104 described
previously.
Accordingly, further detailed description of the safety shield is omitted for
brevity.
[0021] FIG.
12 is a perspective view of the housing 208 illustrating that, like the
housing
108, the housing 208 includes an upper flexible arm 244 and a lower flexible
arm 248. FIG
13 is a cross-sectional view of the housing 208 taken along line 13-13 of FIG.
12, and
illustrates that, also like the housing 108, the housing 208 includes a guide
groove 252 that
includes first and second axial portions 256 and 260, and a substantially
helical portion 264
8
CA 2978588 2017-09-07
connecting the first and second axial portions 256 and 260. Additionally, the
upper flexible
arm 244 is disposed on the first axial portion 256 and the lower flexible arm
248 is disposed
on the second axial portion 260. Further, the upper flexible arm 244 includes
a ramp 268
disposed at a free end thereof and the lower flexible arm 248 includes a ramp
hook 272
disposed at a free end thereof. The ramp 268 and the ramp hook 272 function
substantially
similarly to the ramp 194 and ramp 196 described previously. Accordingly,
further detailed
description of the ramp 268 and the ramp-hook 272 are omitted for brevity.
[0022] Unlike the housing 108, however, the upper flexible arm 244 includes a
locking
protrusion 276 at a proximal end thereof for selectively preventing
displacement of the
housing 208 and the plunger 214 relative to the medicament container 220. The
upper
flexible arm 244 also has an unlocking ramp 280 disposed thereon. As described
in greater
detail below, the unlocking ramp 280 interacts with the shield tab 240 to
radially displace
the free end of the upper flexible arm 244, to permit movement of the housing
208 relative
to the medicament container 220. According to one embodiment, as shown in FIG.
13, the
upper flexible arm 244 has two portions. The locking protrusion 276 is
disposed on a first
portion, and the ramp 268 and the unlocking ramp 280 are disposed on a second
portion,
which also includes the first axial portion 256 of the guide groove 252.
[0023]
Referring back to FIG. 11, in the initial state, the locking protrusion 276
engages a
radial flange 284 disposed at a proximal end of the medicament container 220.
This
engagement prevents displacement of the housing 208 and the plunger 214
relative to the
medicament container 220. Thus, when a user applies force to the proximal end
of the
housing 208, the radial flange 284 compresses the biasing member 228, and the
housing
208, injector member 212, and the medicament container 220 distally displace
as a unit
relative to the safety shield 204 until the medicament container 220 reaches
the depth stop
232, which is an injection state shown in FIG. 14. This displacement of the
medicament
container 220 also drives the needle 224 to pierce the patient's skin.
[0024] As shown in FIG 14, as the housing 208 and medicament container 220
reach the
injection state, the shield tab 240 travels in the first axial portion 256 and
engages the
unlocking ramp 280 to radially displace a free end of the upper flexible arm
244, thereby
disengaging the locking protrusion 276 from the radial flange 284.
Accordingly, because the
locking protrusion 276 no longer engages the radial flange 284, the housing
208 (as well as
9
CA 2978588 2017-09-07
the stopper 216 and the plunger 214, which contacts the housing 208) is
displaceable
relative to the medicament container 220. Thus, as the user continues to apply
force to the
proximal end of the housing 208, as shown in FIG. 15, the housing 208 and the
injector
member 212 displace distally relative to the medicament container 220,
expelling the
medicament from the medicament container 220.
10025] Additionally, during this distal displacement of the housing 208
relative to the
safety shield 204, the shield tab 240 continues to travel proximally relative
to the first axial
portion 256 of the guide groove 252. In other words, the engagement of the
shield tab 240
and the first axial portion 256 constrains the displacement of the housing 208
relative to the
safety shield 204 to be axial and prevents rotation of the housing 208
relative to the safety
shield 204. As the housing approaches the distal end of its stroke and the
medicament
container 220 nears the depth stop 232, the shield tab 240 passes the ramp 268
and radially
displaces the free end of the upper flexible arm 244. And as the medicament
container 220
engages the depth stop 232, the shield tab 240 completes passing the ramp 268
and reaches
the proximal end of the first axial portion 256. After the shield tab 240
passes the ramp 268,
the free end of the upper flexible arm 244 snaps back to form a portion of the
helical portion
264 of the guiding groove 252 and to prevent subsequent axial movement of the
shield tab
240 in the first axial portion 256.
[0026] Similar to the injection device 100 described previously,
subsequent to the
injection of the medicament, the user releases the housing 208 and the biasing
member 228
proximally displaces the housing 208 (as well as the medicament container 220
and the
injector member 212) relative to the safety shield 204, thereby displacing the
medicament
container 220 (and the needle 224) to a withdrawn position. Because the shield
tab 240
engages the helical portion 264 of the guide groove 252, during a first
portion of the
proximal displacement, the housing 208 rotates until the shield tab 240
reaches the proximal
end of the second axial portion 260. At this point, the biasing member 228
continues to
proximally displace the housing 208 and the engagement of the shield tab 240
in the second
axial portion 260 constrains the proximal displacement of the housing 208 to
be axial. As
the housing 208 nears completion of its proximal displacement, the shield tab
240 passes
the ramp hook 272 of the lower flexible arm 248 and radially displaces the
free end of the
lower flexible arm 248. And as the housing 208 completes its proximal
displacement
(shown in FIG 16), the shield tab 240 completes passing the ramp hook 272 and
reaches the
CA 2978588 2017-09-07
distal end of the second axial portion 260. After the shield tab 240 passes
the ramp hook
272, the free end of the lower flexible arm 248 snaps back to prevent
subsequent axial
movement of the shield tab 240 in the second axial portion 260. In other
words, the free end
of the lower flexible arm 248 locks the shield tab 240 and prevents subsequent
displacement
of the housing 208 relative to the safety shield 204, thereby fixing the
injection device 200
in a post-injection safe state.
[0027] FIG
17 is a perspective view of an injection device 300 in an initial state and
FIG
18 is a cross-sectional view of the device 300. As shown in FIGS. 17 and 18,
the injection
device 300 includes a safety shield 304 with a surface 306 for contacting a
patient's skin
disposed at a distal end thereof, a medicament container 308 slidably
connected to the
safety shield 304, an inner housing 312 slidably connected to the safety
shield 304, and a
needle shield 316 for selectively covering a distal end of a needle 324. The
medicament
container 308 may be made of, for example, glass or plastic. According to one
embodiment,
the safety shield 304 includes a pair of locking tabs 318, which are biased
radially inward.
The injection device 300 also includes a needle hub 320 slidably connected to
the inner
housing 312. The double-ended needle 324 is affixed to the needle hub 320. The
injection
device 300 further includes a biasing member 328 disposed within the safety
shield 304 and
proximally biasing the medicament cartridge 308, and a stopper 332 slidably
disposed in the
medicament cartridge 308. According to one embodiment, the inner housing 312
has a barb
334 at the proximal end thereof engaged with a corresponding recess 338 in the
distal end of
the stopper 332, to fix the stopper 332 to the inner housing 312.
[0028] The needle hub 320 has a radial protrusion 336 disposed at a proximal
end thereof
and the inner housing 312 includes a pair of detents or receiving grooves 340
(shown in
FIG. 19) corresponding to the radial protrusion 336. According to one
embodiment, the
radial protrusion 336 and the receiving grooves 340 are circumferential. As
discussed in
greater detail below, the needle hub 320 is movable from a first position, in
which the radial
protrusion 336 is disposed in a distal one of the receiving groove 340, to a
second position,
in which the radial protrusion 336 is disposed in a proximal one of the
receiving grooves
340.
[0029] According to one embodiment, the inner housing 312 also includes a pair
of cam
tracks 344 that slidably receive a pair of cam tabs 348 of the needle shield
316. As shown in
11
CA 2978588 2017-09-07
FIG. 19, each cam track 344 includes a first, substantially helical portion
352 and a second,
substantially linear portion 356. As the user rotates the needle shield 316,
the cam tabs 348
travel along the helical portions 352 until reaching the end of the helical
portions 352 (and
the beginning of the linear portions 356). This rotation of the needle shield
316 proximally
displaces the needle hub 320 from the first position to the second position
and pierces the
stopper 332 with the proximal end of the needle 324, as shown in FIG. 20.
[0030]
Subsequently, with the cam tabs 348 disposed in the linear portions 356, the
user
distally displaces the needle shield 316 to remove it from the injection
device 300. The
injection device 300, as shown in FIG. 21, is now ready for injection.
[0031] Next, the user places the injection device 300 so that the surface 306
of the safety
shield 304 contacts the user's skin and presses down on the medicament
container 308,
compressing the biasing member 328. According to one embodiment, the
combination of
forces of the back pressure of the medicament in the medicament container 308
and the
friction between the stopper 332 and the medicament container 308 is greater
than the
combination of the force from the biasing member 328 and the force required
for the needle
324 to pierce the patient's skin, so that upon distal displacement of the
medicament
container 308, the needle 324 pierces the patient's skin prior to dispensing
of the
medicament. This downward pressure on the medicament container 308 drives the
needle
324 into the patient's skin until the inner housing 312 contacts the patient's
skin, as shown in
FIG. 22.
[0032] Once the inner housing 312 contact the patient's skin, continued
downward
pressure on the medicament container 308 expels medicament from the medicament
container 308 through the needle 324 until the medicament container 308
reaches the end of
its stroke, as shown in FIG 23. According to one embodiment, at the end of the
medicament
container's stroke, the proximal end of the medicament container 308 is
substantially flush
with the proximal end of the safety shield 304.
[0033] Subsequent to the injection of the medicament, the user releases the
medicament
container 308, and the force of the biasing member 328 proximally displaces
the
medicament container 308 (as well as the inner housing 312 and the needle
324). Once the
distal end of the inner housing 312 passes the locking tabs 318, the locking
tabs 318 snap
radially inward due to their radially inward bias. In this position, as shown
in FIG. 24, the
12
CA 2978588 2017-09-07
locking tabs 318 prevent subsequent distal displacement of the inner housing
312 therepast,
and thus, prevent re-use of the injection device 300.
100341 Embodiments of the present invention are user-friendly, and can hide
the needle
prior to injection, thereby making it less intimidating to users who might be
unaccustomed
to injections. Additionally, in embodiments of the present invention, the
needle insertion
and injection stroke can be achieved in one single motion. Further, the needle
can be
automatically shielded once the device is removed from the skin in embodiments
of the
present invention. Moreover, the compact size and low parts count of
embodiments of the
present invention can reduce manufacturing costs as well as transportation and
storage
costs.
[0035] Compared to traditional autoinjectors, the compact size and low parts
count of
embodiments of the present invention can be achieved by eliminating some of
the higher-
order features of such auto injectors. For example, embodiments of the present
invention do
not require automatic, spring-loaded pushing mechanisms that make an
autoinjector
"automatic." Instead, users can apply the necessary force. To ensure that
users apply a
minimum required force and also ensure a swift needle insertion, embodiments
of the
present invention can have a force-based detent that the user needs to
overcome before the
injection can begin. Once the detent is overcome, the needle assembly snaps
into the skin
and then the injection begins. By eliminating the requirement for an
automatic, spring-
loaded pushing mechanism, other features can also be eliminated, such as an
activation
button, and a spring-loaded safety device that only allows the injector to be
triggered once it
is pushed against an object.
Although only a few exemplary embodiments of the present invention have been
described
in detail above, those skilled in the art will readily appreciate that many
modifications are
possible in the exemplary embodiments without materially departing from the
novel
teachings and advantages of this invention. Accordingly, all such
modifications are intended
to be included within the scope of the appended claims and equivalents
thereof.
13
CA 2978588 2017-09-07
